Andrew Rackear
Overview
Andrew Rackear received an average of $657K in total compensation, including $256K in salary, at Enzon Pharmaceuticals from 2011 to 2016.
Source: SEC filings on May 12, 2017, April 16, 2014, and October 11, 2013.
Related executives
We found 12 more executives who work or worked at Enzon Pharmaceuticals.
Richard Feinstein
Enzon Pharmaceuticals
Chief Financial Officer
George Hebard
Enzon Pharmaceuticals
Chief Operating Officer
Aby Buchbinder
Enzon Pharmaceuticals
Former Vice President, Clinical Development
Charles Conover
Enzon Pharmaceuticals
Former Senior Vice President of Research & Development, Program Management
Timothy Daly
Enzon Pharmaceuticals
Chief Accounting Officer
Ana Stancic
Enzon Pharmaceuticals
Chief Financial Officer
Jeffrey Buchalter
Enzon Pharmaceuticals
Chief Executive Officer
Ralph del Campo
Enzon Pharmaceuticals